Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05422703Completed
Trial (2 arms), sponsored by Cairo University. Primary endpoints: Facial swelling at 2 weeks, Facial pain at 2 weeks and 1 more. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05422703.